11th Dec 2006 15:45
Allergy Therapeutics PLC11 December 2006 Allergy Therapeutics plc ("the Company") The Company received notification on 11 December 2006 that FidelityInternational Limited ("FIL") and its direct and indirect subsidiaries,including Fidelity Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST),Fidelity Investments Advisory (Korea) Limited (FIA(K)L), Fidelity InvestmentsManagement (Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") andFidelity Investments International (FII), investment managers for various non-USinvestment companies and institutional clients, are together interested in atotal of 11,238,773 ordinary shares in the Company, representing approximately13.71 per cent. of the Company's issued share capital. This shareholding is registered as follows: Shares held Management Company Nominee/Registered Name 174,500 FPM Northern Trust London 947,136 FPM JP Morgan, Bournemouth 772,800 FPM Northern Trust London 684,400 FPM Mellon Bank 635,684 FPM State Str Bk and Tr Co Lndn 459,000 FPM Bank of New York Brussels 302,100 FPM Bankers Trust London 174,300 FPM Midland Securities Services 5,048,298 FISL JP Morgan, Bournemouth 1,167,612 FIL JP Morgan, Bournemouth 713,243 FIL Brown Bros Harrimn Ltd Lux 159,700 FIL Bank of New York Brussels 11,238,773 Total holding This notifiable interest also comprises the notifiable interest of Mr Edward C.Johnson III, a principal shareholder of Fidelity International Limited, andinterests held on behalf of authorised unit trust schemes in the United Kingdom. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.